SANDI ENGLER: Open Payments
NPI 1588643860 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 54 payments from 19 companies in 2025. Trend: 2023 $1,443 · 2024 $1,359 · 2025 $1,091
Food & beverage: $1,091
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $244 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $158 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $104 |
| ABBVIE INC. | 6 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Astellas Pharma US Inc | 2 | $47 |
| PFIZER INC. | 2 | $37 |
| Abbott Laboratories | 1 | $36 |
Products named: CAPLYTA, AIRSUPRA, FARXIGA, Kerendia, REXULTI, TRINTELLIX, UBRELVY, JARDIANCE.
Industry payments across SC — which companies pay providers there.
